Azenta, Inc. (LON:0HQ1)

London flag London · Delayed Price · Currency is GBP · Price in USD
29.27
0.00 (0.00%)
At close: Sep 8, 2025
Market Cap1.00B
Revenue (ttm)488.17M
Net Income (ttm)-81.45M
Shares Outn/a
EPS (ttm)-1.76
PE Ration/a
Forward PE38.16
Dividendn/a
Ex-Dividend Daten/a
Volume1
Average Volume92
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Range25.12 - 55.00
Beta1.65
RSI44.49
Earnings DateNov 10, 2025

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,... [Read more]

Sector Healthcare
Founded 1978
Employees 3,300
Stock Exchange London Stock Exchange
Ticker Symbol 0HQ1
Full Company Profile

Financial Performance

In 2024, Azenta's revenue was $656.32 million, a decrease of -1.32% compared to the previous year's $665.07 million. Losses were -$164.17 million, 1051.5% more than in 2023.

Financial numbers in USD Financial Statements

News

Azenta (AZTA) Q3 EPS Jumps 36%

5 weeks ago - The Motley Fool

Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance

BURLINGTON, Mass. , Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025.

5 weeks ago - PRNewsWire

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

BURLINGTON, Mass. , July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, ...

6 weeks ago - PRNewsWire

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care

Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated geno...

6 weeks ago - PRNewsWire

Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

BURLINGTON, Mass. , July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conf...

6 weeks ago - PRNewsWire

Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast

BURLINGTON, Mass. , July 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025, on Tuesday August 5, 2025, before the marke...

7 weeks ago - PRNewsWire

Azenta: Down 40% And Still Not Compelling

2 months ago - Seeking Alpha

Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass.

4 months ago - PRNewsWire

Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025

BURLINGTON, Mass. , May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025.

4 months ago - PRNewsWire

Insights Ahead: Azenta's Quarterly Earnings

Azenta (NASDAQ: AZTA) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Azenta will repo...

4 months ago - Benzinga

Azenta Q2 2025 Earnings Preview

4 months ago - Seeking Alpha

Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast

BURLINGTON, Mass. , April 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025, on Wednesday May 7, 2025, before the mar...

5 months ago - PRNewsWire

Azenta: Life Science Business Failing To Come To Life

Struggling to grow, Azenta faces challenges like declining sales and CEO departure.

5 months ago - Seeking Alpha

Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report

BURLINGTON, Mass. , March 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Compan...

6 months ago - PRNewsWire

Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum

BURLINGTON, Mass. , March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y.

6 months ago - PRNewsWire

Azenta Inc (AZTA) Trading Down 5.56% on Feb 27

Azenta Inc (AZTA) Trading Down 5.56% on Feb 27

7 months ago - GuruFocus

Azenta Inc (AZTA) Shares Down 4.06% on Feb 11

Azenta Inc (AZTA) Shares Down 4.06% on Feb 11

7 months ago - GuruFocus